Givosiran 189mg/ml solution for injection is the first drug approved in Europe for the treatment of acute hepatic porphyria (AHP). It is an RNAi drug with which a gene can be silenced. Until now, there has been no approved drug therapy for patients with AHP.
https://www.gelbe-liste.de/neue-medikamente/givlaari-givorisan-hepatische-porphyrie